Information  X 
Enter a valid email address

Minoan Group PLC (MIN)

  Print      Mail a friend       Annual reports

Friday 07 December, 2018

Minoan Group PLC

Update re Placing & Share Issue

RNS Number : 7414J
Minoan Group PLC
07 December 2018
 

7 December 2018

 

MINOAN GROUP PLC

("Minoan")

 

Update re Placing & Share Issue

 

Following its announcement on 3 December 2018 of a Placing and Share Issue, Minoan announces that application will be made for the 31,000,000 New Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will now be effective on 10 December 2018.

As announced, the New Ordinary Shares are being allotted and issued under the authorities in place following Minoan's last Annual General Meeting held on 30 April 2018. Following Admission, there will be a total of 259,903,442 Ordinary Shares in issue. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Minoan under the FCA's Disclosure and Transparency Rules. 

For further information please visit www.minoangroup.com or contact:

Minoan Group Plc


Christopher Egleton

[email protected]

Bill Cole

020 8253 4305



WH Ireland Limited

020 7220 1666

Adrian Hadden/Chris Viggor




Cornhill Capital Limited

020 7710 9610

Daniel Gee



 

Sapience Communications Limited

020 3195 3240

Richard Morgan Evans


 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MSCDMMGZNVGGRZM

a d v e r t i s e m e n t